SCHEMBL7717518

SCHEMBL7717518

CCOC(=O)C(C)OS(=O)(=O)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
LMNA P02545 2/20 0.36
HSD17B10 Q99714 1/20 0.36
ALOX15 P16050 1/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
KMT2A Q03164 1/20 0.33
TRPA1 O75762 1/20 0.32
AURKA O14965 1/20 0.31
NTRK1 P04629 1/20 0.31
HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7717519 1.00 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL12375335 1.00 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL7755094 0.81 ALDH1A1 (0.44) ALDH1A1LMNAL3MBTL1CA1CA2
SCHEMBL7755090 0.81 ALDH1A1 (0.44) ALDH1A1LMNAL3MBTL1CA1CA2
SCHEMBL6682528 0.81 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL17469834 0.81 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL2329267 0.81 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL28855151 0.81 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL3395531 0.81 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10ALOX15MGAM
SCHEMBL10705113 0.79 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10ALOX15MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1075463-A1 CONVERSION OF A HYDROXY GROUP IN CERTAIN ALCOHOLS INTO A FLUOROSULFONATE ESTER OR A TRIFLUOROMETHYLSULFONATE ESTER Loewenthal, Hans Jacob Edgar (IL) 2001-02-14 EP claimed
WO-1999055666-A1 CONVERSION OF A HYDROXY GROUP IN CERTAIN ALCOHOLS INTO A FLUOROSULFONATE ESTER OR A TRIFLUOROMETHYLSULFONATE ESTER LOEWENTHAL HANS JACOB EDGAR (IL) 1999-11-04 WO claimed
EP-2357164-B1 PROCESS FOR PRODUCING -SUBSTITUTED ESTER CENTRAL GLASS CO LTD (JP) 2015-03-25 EP disclosed
US-8835669-B2 Method for producing fluorosulfuric acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-09-16 US disclosed
US-8835669-B2 Method for producing fluorosulfuric acid ester CENTRAL GLASS COMPANY, LIMITED (JP) 2014-09-16 US disclosed
WO-2014104221-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY USING SAME 三菱化学株式会社 (JP) 2014-07-03 WO disclosed
EP-2357168-B1 METHOD FOR PRODUCING FLUOROSULFURIC ACID ESTER CENTRAL GLASS CO LTD (JP) 2013-07-17 EP disclosed
US-8278476-B2 Process for producing α-substituted ester CENTRAL GLASS COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20110213176-A1 Process for Producing alpha Substituted Ester CENTRAL GLASS COMPANY, LIMITED (JP) 2011-09-01 US disclosed
US-20110201825-A1 Method for Producing Fluorosulfuric Acid Ester CENTRAL GLASS COMPANY, LIMITED (JP) 2011-08-18 US disclosed
US-6395918-B1 Conversion of a hydroxy group in certain alcohols into a fluorosulfonate ester or a trifluoromethylsulfonate ester LOEWENTHAL HANS JACOB EDGAR (IL) 2002-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201825-A1 Method for Producing Fluorosulfuric Acid Ester PHF2, SPOUT1, HACL2 ALDH1A1 125/4885LMNA 3580/4885HSD17B10 88/4885
US-20110213176-A1 Process for Producing alpha Substituted Ester CYP8B1, HSD11B1, GRHPR ALDH1A1 768/4885LMNA 3704/4885HSD17B10 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.